BLEOCIP BLEMYCIN INJECTION

Get a Price/Quote

MOQ : 1 Bottle

BLEOCIP BLEMYCIN INJECTION Specification

Indication
Cancer, such as lymphoma, carcinoma, testicular cancer, squamous cell cancer

Origin of Medicine
Allopathic

Dosage Form
Injection

Salt Composition
Bleomycin Sulphate

Pacakaging (Quantity Per Box)
1 vial per box

Drug Type
Injection

Ingredients
Bleomycin

Physical Form
Liquid

Function

Recommended For
Adults / Patients undergoing chemotherapy

Dosage
15MG

Dosage Guidelines
As directed by the physician

Suitable For
Adults

Quantity
1 vial

Storage Instructions
Store below 25C, protected from light

BLEOCIP BLEMYCIN INJECTION Trade Information

Minimum Order Quantity
1 Bottle

Packaging Details
PACK OF 1 VIAL

Main Domestic Market
All India

About BLEOCIP BLEMYCIN INJECTION

PRODUCTDETAILS

BRAND NAME: BLEOCIP
CONTENT: BLEOMYCIN
STRENGTH: 15MG
PACKAGING SIZE: VIAL
MANUFACTURED BY: CIPLA

Note:- Bleocip Is APrescription Drug And Should Be Used Under Proper Medical GuidanceAndAdvice. Do Not Share The Medicine With Others, Since They May BeSuffering From A Problem That Is Not Effectively Treated By ThisDrug...............

Versatile Administration for Cancer Care

BLEOCIP Bleomycin Injection offers flexible administration routes, including intravenous, intramuscular, subcutaneous, and intra-pleural injections. This versatility allows oncologists to tailor treatment approaches based on individual patient needs and specific cancer types. The sterile powder requires reconstitution with sterile water before administration, ensuring safety and effectiveness for adult patients during chemotherapy.

Certified Quality and Trusted Manufacturing

Marketed by Cipla, BLEOCIP Bleomycin Injection is produced in a WHO GMP-certified facility and carries US FDA approval, reflecting high standards of quality and patient safety. The clear to pale yellow solution is available in a single-dose vial, designed for convenient storage and handling. Each vial contains 15 mg of Bleomycin Sulphate suitable for oncology therapy.

Effective Therapeutic Class for Oncology

Belonging to the antineoplastic class, BLEOCIP Bleomycin Injection is recommended as an integral part of chemotherapy regimens for adults with certain cancers, including lymphoma, squamous cell carcinoma, and testicular cancer. Its allopathic origin and established therapeutic efficacy make it a reliable option for oncologists and healthcare providers.

FAQs of BLEOCIP BLEMYCIN INJECTION:

Q: How is BLEOCIP Bleomycin Injection administered to patients?

A: BLEOCIP Bleomycin Injection is administered by a qualified healthcare provider using one of several methodsintravenous, intramuscular, subcutaneous, or intra-pleuralinjection. The sterile powder is first reconstituted with sterile water before use to ensure proper delivery and effectiveness.

Q: What types of cancer is BLEOCIP Bleomycin Injection used to treat?

A: This medication is indicated for treating several types of cancer, including lymphoma, testicular cancer, squamous cell carcinoma, and other carcinomas, as advised by your oncologist.

Q: When should BLEOCIP Bleomycin Injection be used during cancer therapy?

A: The timing and frequency of Bleomycin injections are determined by your oncologist based on your specific diagnosis, treatment plan, and response to therapy. Always follow your physicians dosage guidelines.

Q: Where should BLEOCIP Bleomycin Injection be stored before use?

A: Store the vials below 25C and protect them from light to maintain the stability and efficacy of the medication. Follow the storage instructions on the packaging closely.

Q: What is the process for preparing BLEOCIP Bleomycin Injection for use?

A: Before administration, the sterile powder in each vial should be reconstituted with sterile water by a healthcare professional. It should be prepared and injected according to medical protocols within the appropriate healthcare setting.

Q: What are the primary benefits of using BLEOCIP Bleomycin Injection?

A: This medication provides antineoplastic action, helping to destroy cancer cells and slow tumor progression. Its effectiveness and flexible administration routes support a broad range of treatment protocols in adult oncology patients.

Q: Is BLEOCIP Bleomycin Injection suitable for self-administration at home?

A: No; this injection must be administered by a trained healthcare professional in a clinical environment. It is not intended for self-administration due to the need for proper reconstitution and monitoring.

Tell us about your requirement